Unit of Otorhinolaryngology - Head and Neck Surgery, ASST Spedali Civili di Brescia, Brescia, Italy.
Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, School of Medicine, Brescia, Italy.
Acta Otorhinolaryngol Ital. 2024 Feb;44(1):1-12. doi: 10.14639/0392-100X-N2762.
The current study systematically reviews the literature about financial toxicity (FT) in head and neck cancer patients. Three databases were reviewed: PubMed, Scopus and Web of Science.
Full text English papers published from 2000 to 2022 reporting on quantitative results about FT in head and neck cancer survivors collected through structured questionnaires or interviews were included.
Twenty-seven articles were included. Most of the articles were published after 2015 and from United States. There was a slight prevalence of papers dealing with oropharyngeal cancer, squamous-cell carcinoma and locally advanced head and neck cancer. Measures of FT were obtained through validated questionnaires like COST, FIT and FDQ. Collected data were mostly referrable to financial spending, financial resources, psychosocial aspect, support seeking, coping care and coping lifestyle subdomain. FT scores by COST were found to be worse in the COVID era. Financial counseling and adequate information about the costs of treatment were two effective strategies to mitigate FT.
FT is a relatively new challenge in head and neck cancer treatment, whose expenses are higher than therapies for other cancers. A universal method to assess FT and a unified guideline for the administration of questionnaires are needed to mitigate FT and to improve patient outcomes.
本研究系统地回顾了有关头颈部癌症患者财务毒性（FT）的文献。共检索了三个数据库：PubMed、Scopus 和 Web of Science。
纳入了 2000 年至 2022 年期间发表的、通过结构化问卷或访谈收集头颈部癌症幸存者中有关 FT 的定量结果的全文英文论文。
共纳入 27 篇文章。大多数文章发表于 2015 年之后，且来自美国。有一些文章涉及口咽癌、鳞状细胞癌和局部晚期头颈部癌症。FT 的测量是通过 COST、FIT 和 FDQ 等经过验证的问卷进行的。收集的数据主要与财务支出、财务资源、心理社会方面、寻求支持、应对护理和应对生活方式等方面有关。COST 评估的 FT 评分在 COVID 时代更差。财务咨询和充分了解治疗费用是减轻 FT 的两种有效策略。
FT 是头颈部癌症治疗中一个相对较新的挑战，其费用高于其他癌症的治疗费用。需要一种通用的方法来评估 FT，并制定统一的问卷管理指南，以减轻 FT 并改善患者结局。
